Thermo Fisher Scientific to buy Olink in $3.1B deal
Waltham, MA, October 17, 2023 (Reuters) -- Thermo Fisher Scientific (TMO.N) announced plans to purchase Olink Holding AB (OLK.O) for $3.1 billion. This acquisition bolsters the U.S. medical equipment company's life sciences portfolio, specifically in the field of drug discovery.
Read full article here.
Comentários